Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα
Glycobiology · 2024
DOI: 10.1093/glycob/cwae042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glycobiology, 2024. Verfasst von Weihua Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapeutic Glycoengineering and Immunology, Section for Medical Biotechnology, Department of Biotechnology and Biomedicine, Technical University …. Hauptthemen laut MEDLINE: Dendritic Cells, Sialyltransferases, CD4-Positive T-Lymphocytes, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Novo Nordisk Foundation.
Abstract (Originalsprache)
Dendritic cells (DCs) are central for the initiation and regulation of appropriate immune responses. While several studies suggest important regulatory roles of sialoglycans in DC biology, our understanding is still inadequate primarily due to a lack of appropriate models. Previous approaches based on enzymatic- or metabolic-glycoengineering and primary cell isolation from genetically modified mice have limitations related to specificity, stability, and species differences. This study addresses these challenges by introducing a workflow to genetically glycoengineer the human DC precursor cell line MUTZ-3, described to differentiate and maturate into fully functional dendritic cells, using CRISPR-Cas9, thereby providing and validating the first isogenic cell model for investigating glycan alteration on human DC differentiation, maturation, and activity. By knocking out (KO) the ST6GAL1 gene, we generated isogenic cells devoid of ST6GAL1-mediated α(2,6)-linked sialylation, allowing for a comprehensive investigation into its impact on DC function. Glycan profiling using lectin binding assay and functional studies revealed that ST6GAL1 KO increased the expression of important antigen presenting and co-stimulatory surface receptors and a specifically increased activation of allogenic human CD4 + T cells. Additionally, ST6GAL1 KO induces significant changes in surface marker expression and cytokine response to TNFα-induced maturation, and it affects migration and the endocytic capacity. These results indicate that genetic glycoengineering of the isogenic MUTZ-3 cellular model offers a valuable tool to study how specific glycan structures influence human DC biology, contributing to our understanding of glycoimmunology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapeutic Glycoengineering and Immunology, Section for Medical Biotechnology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kgs Lyngby 2800, Denmark.
ORCID-Profile: Sarah Line Skovbakke
Förderung
- Novo Nordisk Foundation
Zitieren
APA
Tian, W., Blomberg, A. L., Steinberg, K. E., Henriksen, B. L., Jørgensen, J. S., Skovgaard, K., Skovbakke, S. L., & Goletz, S. (2024). Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα. Glycobiology. https://doi.org/10.1093/glycob/cwae042
Vancouver
Tian W, Blomberg AL, Steinberg KE, Henriksen BL, Jørgensen JS, Skovgaard K, et al. Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα. Glycobiology. 2024. doi:10.1093/glycob/cwae042
BibTeX
@article{Tian2024,
author = {Tian, Weihua and Blomberg, Anne Louise and Steinberg, Kaylin Elisabeth and Henriksen, Betina Lyngfeldt and Jørgensen, Josefine Søborg and Skovgaard, Kerstin and Skovbakke, Sarah Line and Goletz, Steffen},
title = {Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα},
journal = {Glycobiology},
year = {2024},
doi = {10.1093/glycob/cwae042}
}
EUVIMED